SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported): November 21, 2014


PROBE MANUFACTURING, INC.

(Exact name of Company as specified in its charter)





Nevada

333-125678

20-2675800

(State or other jurisdiction

(Commission File Number)

(IRS Employer

of Incorporation)


Identification Number)



17475 Gillette Blvd.,

Irvine, CA 92614



(Address of principal executive offices)




Phone: (949) 273-4990



(Company s Telephone Number)




Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:


 Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


 Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))



Item 1.01 Entry into a Material Definitive Agreement.


On November 21, 2014, Probe Manufacturing, Inc., a public Nevada corporation (the Company ), located at 17475 Gillette Blvd., Irvine CA 92614,  entered into an Exclusive OEM  and Distribution agreement with S-Ray INCORPORATED, a private Nevada corporation ( S-Ray ), located at 50 West Liberty Street, Suite 880, Reno Nevada 89501, which provides that S-Ray designs and owns the intellectual property rights of ultrasound technology for dental use, including the ClearView LAB product, and Probe Manufacturing, Inc. desires to Manufacture and distribute the ClearView LAB product on an exclusive worldwide basis with revenue targeted to start in the 1st Quarter of 2015.




The foregoing summary description of the terms of the OEM Agreement may not contain all information that is of interest to the reader. For further information regarding the terms and conditions of the agreement, this reference is made to such agreement, which is filed as Exhibit 10.1 hereto and is incorporated herein by this reference.


ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS




  (d)

Exhibits

 



Exhibit No.

Description of Exhibit


10.1

OEM Agreement between the Company and S-Ray INCORPORATED, dated November 21st, 2014


SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.



Probe Manufacturing, Inc.

Date: November 24, 2014

By: /s/ Kambiz Mahdi

Kambiz Mahdi

Chief Executive Officer










EXCLUSIVE MANUFACTURING AND DISTRIBUTION AGREEMENT

CONFIDENTIAL



This Agreement (“Agreement”) is entered into and effective this 21 ST day of November, 2014 (“Effective Date”), by and between S-Ray, Incorporated. (hereinafter referred to as “S-Ray”), a Nevada Corporation, with offices at 50 West Liberty Street, Suite 880, Reno, Nevada 89501 and Probe Manufacturing, Inc. (hereinafter referred to as “PMI”), a Nevada corporation having offices at 17475 Gillette Ave., Irvine, CA 92614, (collectively the “Parties” and individually a “Party”).


WHEREAS, S-Ray designs and owns the intellectual property rights of ultrasound technology for dental use, including the ClearView LAB product.


WHEREAS, PMI desires to Manufacture and Distribute the ClearView LAB product on an exclusive, worldwide basis.


NOW, THEREFORE, in consideration of the mutual promises and covenants contained herein, the parties hereto agree as follows:


1.

Term of the Agreement


The term of this Agreement shall commence on the Effective Date and shall continue for Five (5) years. This agreement can be mutually terminated and /or extended anytime within the Five (5) year period.


2.

Product Brand & Territory


2.1.

PMI will manufacture and distribute ClearView LAB.


2.2.

PMI will market and sell the above mentioned products on an exclusive basis worldwide.


2.3.

PMI may, with the approval of S-Ray, name distribution partners on a worldwide basis.  PMI will bear the costs for those distribution partners, including support and commissions.


3.

Pricing & Royalty Term


S-Ray grants PMI the control of pricing, manufacturing cost and profit.

S-Ray would be paid an annual royalty of 6% of total ClearView LAB product revenue payable commencing, commencing January 31, 2015 and on each and every year this agreement is in effect.


4.

Product Commitment


4.1.

S-Ray agrees to provide PMI with the manufacturing and distribution commitment from the initial customer by December 31, 2014.  


4.2.

S-Ray agrees to provide PMI with the manufacturing documentation in order for PMI to meet the delivery commitment to its customer by January 15, 2015.


4.3.

In the event customers specify custom designs, PMI and S-Ray will work cooperatively to integrate those designs into the product in a prompt manner.


4.4.

S-Ray agrees to pay PMI non-recurring charges to enable manufacturing of the above mentioned products.


5.

Marketing Rights


5.1.

PMI will sell the products worldwide on an exclusive basis.


5.2.

S-Ray will provide its existing marketing collaterals and test reports.



-1-



6.

Exclusivity


6.1.

PMI is granted exclusivity to manufacture and distribute the ClearView LAB product.


6.2.

PMI is granted a 30 day Right of First Refusal as manufacturing and distribution source for additional S-Ray products.


7. Product Specification


7.1. A preliminary description of the ClearView LAB is attached as Addendum 1.

  

7.2. S-Ray and PMI will make best efforts to deliver products meeting the criteria described in Addendum 1.  Any substantial modification to the product will require mutual acceptance.


7.3. S-Ray and PMI reserve the right to issue updated features from time to time with mutual acceptance.


8. Product Support


8.1. PMI will provide technical support to its clients for the above mentioned products; however S-Ray will provide required assistance and training.


9. Product Warranty


9.1. PMI will offer twelve (12) month warranty from the delivery of the product to its clients.


9.2. Other terms according to PMI’s standard terms and conditions of sale published.

  

9.3. Any extended warranty should be negotiated separately.


10.  Confidentiality


This agreement is confidential and contains Trade Secrets and is identified as Confidential information as noted in the Mutual Non-Disclosure Agreement attached to this Agreement as Addendum 2.  This Agreement may be referenced in public disclosure as “Exclusive Manufacturing and Distribution Rights” granted to PMI.  No other disclosures regarding this Agreement may be made with the written permission of the Chief Executive Officers of both S-Ray and PMI.


11. Change in Control


In the event of a Change in Control of S-Ray, as defined as a change in BOTH the Chief Executive Officer and the Chairman, Probe has the right to terminate the agreement and receive the balance of the remaining Minimum Annual Revenue Target.


12. Annual Target Revenue


Minimum Annual Revenue Target is referenced in Point 11 of this Agreement.  It is defined as the minimum annual gross revenue to PMI from the sales of the ClearView LAB product.


The Minimum Annual Revenue Target as follows:

1.

2015 $25 million

2.

2016 $25 million

3.

2017 $25 million  


There is no limit placed on the annual revenue which PMI may receive from this agreement.




-2-


13. Miscellaneous


13.1. PMI is granted the right to sell or assign the manufacturing and distribution rights to a third party with the approval of S-Ray.


13.2. Governing Law.  The law, without regard to conflicts of laws principles, of the State of Nevada will govern all questions concerning the construction, validity and interpretation of this Agreement and the performance of the obligations imposed by this Agreement.


13.3. Forum.  Any dispute arising out of or in connection with this Agreement, or arising out or in connection with the relationship between S-Ray and PMI shall be settled by filing a claim or suit in an appropriate court in Nevada and in no other forum.


13.4. This agreement contains the entire agreement between both parties. Any modifications of this agreement or waivers of the terms and conditions shall be in writing executed by both parties.



S-Ray Incorporated


By: ________________________________


Name: Steve Baird

Title: Chief Executive Officer


Date: _______________________



Probe Manufacturing, Inc.


By: ________________________________


Name: Kam Mahdi

Title: Chief Executive Officer


Date: _______________________






-3-